Valuation: Becton, Dickinson and Company

Market Cap 49.22B 43.01B 40.43B 36.89B 69.24B 4,705B 69.25B 485B 187B 2,403B 185B 181B 7,746B P/E 2026 *
34.8x
P/E 2027 * 19.4x
Enterprise Value 65.11B 56.9B 53.47B 48.8B 91.59B 6,224B 91.6B 642B 248B 3,178B 244B 239B 10,247B EV / Sales 2026 *
3.38x
EV / Sales 2027 * 3.2x
Free-Float
73.18%
Yield 2026 *
2.17%
Yield 2027 * 2.21%
1 day+1.30%
1 week-1.34%
Current month-2.49%
1 month-3.84%
3 months+30.35%
6 months+17.40%
Current year-5.49%
1 week 179.42
Extreme 179.42
186.27
1 month 175.2
Extreme 175.2
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
269.52
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Tax

Chief Financial Officer

-190 0.0001%
8/26/26 Sell

Executive/Senior Manager

-165 0.0001%
8/20/26 Tax

Executive/Senior Manager

-1,049 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-1.34%-1.68%-30.84% 49.22B
+1.14%+2.17%-23.70%+6.21% 178B
-0.64%-2.58%-3.48%+13.78% 117B
-0.43%-2.38%+9.28%+69.71% 60.39B
-0.22%+0.78%+10.27%+47.46% 48.02B
+0.84%+3.84%+29.15%+2.59% 33.65B
+6.88%+5.84% - - 28.04B
+3.50%+2.46%+48.27%+0.39% 25.46B
+2.38%+8.63%+11.66%-10.18% 22.5B
-2.33%-1.08%-8.97%+8.33% 20.96B
Average +1.24%+1.04%+7.87%+11.94% 58.38B
Weighted average by Cap. +0.81%-0.14%-2.48%+13.92%

Financials

2026 *2027 *
Net sales 19.26B 16.83B 15.82B 14.44B 27.09B 1,841B 27.1B 190B 73.26B 940B 72.33B 70.75B 3,031B 19.73B 17.24B 16.21B 14.79B 27.76B 1,886B 27.76B 195B 75.06B 963B 74.11B 72.48B 3,106B
Net income 1.44B 1.26B 1.18B 1.08B 2.02B 137B 2.02B 14.16B 5.46B 70.14B 5.4B 5.28B 226B 2.34B 2.04B 1.92B 1.75B 3.29B 224B 3.29B 23.06B 8.9B 114B 8.79B 8.59B 368B
Net Debt 15.88B 13.88B 13.05B 11.91B 22.35B 1,519B 22.35B 157B 60.42B 775B 59.65B 58.35B 2,500B 13.95B 12.19B 11.46B 10.46B 19.63B 1,334B 19.63B 138B 53.07B 681B 52.39B 51.25B 2,196B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-09-22 US$183.53 +1.56% 589,136
26-09-21 US$180.70 -0.13% 1,461,542
26-09-18 US$180.94 -0.24% 6,416,945
26-09-17 US$181.38 -0.26% 1,839,784
26-09-16 US$181.85 -2.19% 1,734,018
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
180.70USD
Average target price
195.67USD
Spread / Average Target
+8.28%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!